Zinc finger and BTB domain-containing protein 3 is essential for the growth of cancer cells

BMB Reports

Volumn 47, Issue 7, 2014, Pages 405-410

  Lim, Ji Hong ^a  

^a Konkuk University   (South Korea)

Author keywords

Apoptosis; Cancer; ROS; ZBTB3

Indexed keywords

CASPASE 3; CASPASE 9; DNA BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; REPRESSOR PROTEIN; SMALL INTERFERING RNA; ZBTB3 PROTEIN, HUMAN;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL PROLIFERATION; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; RNA INTERFERENCE; TUMOR CELL LINE;

APOPTOSIS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; HEK293 CELLS; HUMANS; POLY(ADP-RIBOSE) POLYMERASES; REACTIVE OXYGEN SPECIES; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84905924657     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2014.47.7.075     Document Type: Article

References (23)

1. Lee, S. U. and Maeda, T. (2012) POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function. Immunol. Rev. 247, 107-119.
2. Kelly, K. F and Daniel, J. M. (2006) POZ for effect-- POZ-ZF transcription factors in cancer and development. Trends. Cell Biol. 16, 578-587.
3. Costoya, J. A. (2007) Functional analysis of the role of POK transcriptional repressors. Brief. Funct. Genomic. Proteomic. 6, 8-18.
4. Perez-Torrado, R., Yamada, D. and Defossez, P. A. (2006) Born to bind: the BTB protein-protein interaction domain. Bioessays 28, 1194-1202.
5. Zheng, J., Xiong, D., Sun, X., Wang, J., Hao, M., Ding, T., Xiao, G., Wang, X., Mao, Y., Fu, Y., Shen, K. and Wang, J. (2012) Signification of hypermethylated in cancer 1 (HIC1) as tumor suppressor gene in tumor progression. Cancer Microenviron 5, 285-293.
6. Boulay, G., Dubuissez, M., Van Rechem, C., Forget, A., Helin, K., Ayrault, O. and Leprince, D. (2012) Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins. J. Biol. Chem. 287, 10509-10524.
7. Albagli-Curiel, O. (2003) Ambivalent role of BCL6 in cell survival and transformation. Oncogene 22, 507-516.
8. Polo, J. M., Dell'Oso, T., Ranuncolo, S. M., Cerchietti, L., Beck, D., Da silva, G. F., Prive, G. G., Licht, J. D. and Melnick, A. (2004) Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. Nat. Med. 10, 1329-1335.
9. Kim, K., Chadalapaka, G., Lee, S. O., Yamada, D., Sastre-Garau, X., Defossez, P. A., Park, Y. Y., Lee, J. S. and Safe, S. (2012) Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer. Oncogene 31, 1034-1044.
10. Irani, K., Xia, Y., Zweier, J. L., Sollott, S. J., Der, C. J., Fearon, E. R., Sundaresan, M., Finkel, T. and Goldschmidt-Clermont, P. J. (1997) Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275, 1649-1652.
11. Wu, W. S. (2006) The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 25, 695-705.
12. Finkel, T. (2011) Signal transduction by reactive oxygen species. J. Cell Biol. 194, 7-15.
13. Sena, L. A. and Chandel, N. S. (2012) Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 48, 158-167.
14. Dixon, S. J. and Stockwell, B. R. (2014) The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 10, 9-17.
15. Trachootham, D., Alexandre, J. and Huang, P. (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?. Nat. Rev. Drug. Discov. 8, 579-591.
16. Vazquez, F., Lim, J. H., Chim, H., Bhalla, K., Girnun, G., Pierce, K., Clish, C. B., Granter, S. R., Widlund, H. R., Spiegelman, B. M. and Puigserver, P. (2013) PGC1alpha expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell 23, 287-301.
17. Trachootham, D., Zhou, Y., Zhang, H., Demizu, Y., Chen, Z., Pelicano, H., Chiao, P. J., Achanta, G., Arlinghaus, R. B., Liu, J. and Huang, P. (2006) Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 10, 241-252.
18. Singh, A., Misra, V., Thimmulappa, R. K., Lee, H., Ames, S., Hoque, M. O., Herman, J. G., Baylin, S. B., Sidransky, D., Gabrielson, E., Brock, M. V. and Biswal, S. (2006) Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 3, e420.
19. Park, H. J., Carr, J. R., Wang, Z., Nogueira, V., Hay, N., Tyner, A. L., Lau, L. F., Costa, R. H. and Raychaudhuri, P. (2009) FoxM1, a critical regulator of oxidative stress during oncogenesis. EMBO J. 28, 2908-2918.
20. Raj, L., Ide, T., Gurkar, A. U., Foley, M., Schenone, M., Li, X., Tolliday, N. J., Golub, T. R., Carr, S. A., Shamji, A. F., Stern, A. M., Mandinova, A., Schreiber, S. L. and Lee, S. W. (2011) Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475, 231-234.
21. Barrett, C. W., Smith, J. J., Lu, L. C., Markham, N., Stengel, K. R., Short, S. P., Zhang, B., Hunt, A. A., Fingleton, B. M., Carnahan, R. H., Engel, M. E., Chen, X., Beauchamp, R. D., Wilson, K. T., Hiebert, S. W., Reynolds, A. B. and Williams, C. S. (2012) Kaiso directs the transcriptional corepressor MTG16 to the Kaiso binding site in target promoters. PLoS One 7, e51205.
22. Cho, J. H., Kim, M. J., Kim, K. J. and Kim, J. R. (2012) POZ/BTB and AT-hook-containing zinc finger protein 1 (PATZ1) inhibits endothelial cell senescence through a p53 dependent pathway. Cell Death Differ. 19, 703-712.
23. Valentino, T., Palmieri, D., Vitiello, M., Pierantoni, G. M., Fusco, A. and Fedele, M. (2013) PATZ1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context. Cell Death Dis. 4, e963.